Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
We also found that cost remains a substantial barrier to sustained use, with nearly 13% of patients citing affordability as a reason for stopping
Zepbound costs The company that makes Zepbound, Eli Lilly, says the list price is about $1,060 for a four-week supply
GLP-1 agonists offer dual benefits of improved glycaemic control with minimal hypoglycaemia risk when used alone, and facilitation of weight loss
These are approximate ranges from research literature
US$ 28.21
US$ 27.93
US$ 22.51
US$ 22.30
